Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NQO1 | GDSC1000 | pan-cancer | AAC | 0.59 | 7e-50 |
mRNA | NQO1 | CCLE | pan-cancer | AAC | 0.62 | 2e-28 |
mRNA | ABCC3 | GDSC1000 | pan-cancer | AAC | 0.35 | 8e-21 |
mRNA | TNFRSF1A | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-18 |
mRNA | G6PD | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-17 |
mRNA | KIF1A | GDSC1000 | pan-cancer | AAC | -0.31 | 3e-17 |
mRNA | AVPI1 | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-17 |
mRNA | S100A11 | GDSC1000 | pan-cancer | AAC | 0.31 | 7e-17 |
mRNA | SQSTM1 | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-16 |
mRNA | LGALS1 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-16 |